Back to top
more

Envision Healthcare Corporation (EVHC)

(Delayed Data from NYSE)

$45.99 USD

45.99
NA

0.00 (0.00%)

Updated Oct 10, 2018 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Company News For Sep 26, 2018

Companies in the news are: FDS, SONC, AZN and EVHC

    Is Envision Healthcare (EVHC) a Suitable Value Stock Now?

    Let's see if Envision Healthcare Corporation (EVHC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

      EVHC vs. USPH: Which Stock Should Value Investors Buy Now?

      EVHC vs. USPH: Which Stock Is the Better Value Option?

        Is Envision Healthcare (EVHC) a Great Value Stock Right Now?

        Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

          EVHC vs. USPH: Which Stock Is the Better Value Option?

          EVHC vs. USPH: Which Stock Is the Better Value Option?

            Is Envision Healthcare (EVHC) a Great Value Stock Right Now?

            Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

              Why Is Envision Healthcare (EVHC) Up 1.8% Since Last Earnings Report?

              Envision Healthcare (EVHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Envision Healthcare (EVHC) Q2 Earnings Beat, Revenues Miss

                Envision Healthcare (EVHC) Q2 earnings were backed by higher contribution from its segments.

                  Envision Healthcare (EVHC) Surpasses Q2 Earnings Estimates

                  Envision Healthcare (EVHC) delivered earnings and revenue surprises of 4.55% and -1.07%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                    Healthcare Stocks Earnings Due on Aug 6: EVHC, THC, BKD

                    Increased demand for healthcare products and service partly offset by reduced admissions and high costs are likely to affect Q2 earnings of healthcare industry.

                      Envision Healthcare (EVHC) Q2 Earnings: What's in Store?

                      Envision Healthcare (EVHC) Q2 earnings should gain from higher revenues from thePhysician Service segment and gains from cost control initiatives.

                        EVHC vs. ADUS: Which Stock Should Value Investors Buy Now?

                        EVHC vs. ADUS: Which Stock Is the Better Value Option?

                          Envision Healthcare to Go Private With Acquisition by KKR

                          Envision Healthcare to become a private company on acquisition by private equity company KKR.

                            Envision Healthcare's (EVHC) Ratings on Review for Downgrade

                            Moody's Investor Service puts Envision Healthcare's (EVHC) ratings and outlook on review for downgrade.

                              Implied Volatility Surging for Envision Healthcare (EVHC) Stock Options

                              Investors need to pay close attention to Envision Healthcare (EVHC) stock based on the movements in the options market lately.

                                Envision Healthcare (EVHC) Up 15.5% Since Earnings Report: Can It Continue?

                                Envision Healthcare (EVHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  Moving Average Crossover Alert: Envision Healthcare Corporation (EVHC)

                                  Moving Average Crossover Alert: Envision Healthcare Corporation (EVHC)

                                    Amedisys or Chemed: Which is a Better Investment Choice?

                                    After considering various parameters and fundamentals, we help you make a choice between Amedisys (AMED) and Chemed (CHE).

                                      Envision Healthcare (EVHC) Q1 Earnings Beat, Revenues Rise

                                      Envision Healthcare's (EVHC) Q1 earnings gain from by revenue growth at its Physicians Services segment.

                                        The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum

                                        The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum

                                          3 Healthcare Stocks Set to Beat Q1 Earnings Estimates

                                          Elevated flu activity, aging population, high expenses, and a low tax rate would influence healthcare stocks' earnings in Q1.

                                            Healthcare Stocks' Earnings Due on May 7: EVHC, PINC & More

                                            Acute flu, aging population, increase in patient volumes and high claims would affect healthcare companies' Q1 earnings.

                                              Envision Healthcare (EVHC) to Report Q1 Earnings: What's Up?

                                              Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.

                                                Will Cigna (CI) Beat Q1 Earnings Estimates This Time Again?

                                                Cigna (CI) Q1 earnings to see upside from higher revenues, enrollment growth.

                                                  3 Reasons Why You Should Invest in Baxter International Now

                                                  Baxter (BAX) gains ground on strategic buyouts and a raised guidance for 2018.